Abingdon, United Kingdom

Jonathan Paul Shine

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):

Title: Innovations by Jonathan Paul Shine

Introduction

Jonathan Paul Shine is an accomplished inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of integrated stress response pathways. With a total of two patents to his name, Shine's work is focused on developing novel compounds that can be used as medicaments.

Latest Patents

Shine's latest patents include innovative compounds that modulate the integrated stress response pathway. The first patent describes compounds of formula (I) or pharmaceutically acceptable salts, solvates, hydrates, tautomers, or stereoisomers thereof. These compounds are intended for use in pharmaceutical compositions aimed at treating and preventing diseases associated with the integrated stress response. The second patent also focuses on similar compounds, emphasizing their potential as medicaments and their application in addressing various disorders linked to the integrated stress response.

Career Highlights

Shine is currently associated with Evotec International GmbH, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in medicine.

Collaborations

Some of Shine's notable coworkers include Holly Atton and Christopher John Brown. Their collaborative efforts contribute to the innovative environment at Evotec International GmbH.

Conclusion

Jonathan Paul Shine's contributions to the field of pharmaceutical inventions highlight his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…